Aims: To estimate the prevalence of hazardous drinking in individuals aged 50 and older who had or had had cancer in 17 European countries and Israel and to analyze the factors associated with their consumption. Methods: Cross-sectional study based on data from 2011 to 2013 SHARE surveys. A total of 69,509 individuals aged 50 or more from 17 European countries and Israel participated in the study. Prevalence of hazardous drinking in people with cancer was estimated (adapting the SHARE questionnaire to the AUDIT-C). To ascertain whether type of cancer or time since diagnosis were associated with hazardous drinking, Poisson regression models with robust variance were estimated, obtaining prevalence ratios (PR). Results: Overall, 5.4% of participants reported having been diagnosed with cancer. Prevalence of hazardous drinking in people with cancer was 18% in women and 23% in men. After adjusting for various socioeconomic and health variables, no significant differences were observed between hazardous drinking and type of cancer [PR = 0.99 (95% confidence interval (95% CI) = 0.83-1.17) in people with alcohol-related cancers compared to non-alcohol related cancers] and time since diagnosis [PR = 1.01 (95% CI = 0.82-1.25) in people with a cancer diagnosed >5 years ago compared to those diagnosed ≤5 years ago]. Significant differences were found between hazardous drinking and smoking status and self-perceived health. Conclusion: In total, 20% of people diagnosed with cancer were hazardous drinkers, despite the known relationship between alcohol use and a worse prognosis of the disease and an increased likelihood of recurrence. Short Summary: Overall, 20% of people diagnosed with cancer were hazardous drinkers. There were no significant differences in the prevalence of hazardous drinking depending on the type of cancer (alcohol-related versus non-alcohol related cancers). Highest prevalence of hazardous drinking in people with cancer is found in smokers and people with good self-perceived health.
INTRODUCTION
In Europe in 2012, over 3.45 million people were diagnosed with cancer and 1.75 million people died from cancer (Ferlay et al., 2013) . The incidence rate of cancer and its mortality rate are expected to increase due to the ageing of populations and to the entrenchment of health risk behaviors (Thun et al., 2010) . Around 90-95% of cancers are attributable to environmental factors such as diet, tobacco, infections, obesity and alcohol consumption (Anand et al., 2008) . Alcohol consumption is the third most important modifiable risk factor for death and disability and its harmful use ranks among the top five risk factors for disease, disability and death throughout the world (Lim et al., 2012) . Most of the health consequences of alcohol consumption stem from hazardous drinking (Patra et al., 2009) . In some studies, using data from various European countries, the prevalence of hazardous drinking in people aged 50 years or more was~22%, with substantial gender differences (Bosque-Prous et al., 2016) .
Around 5% of total cancers diagnosed are attributable to alcohol use (Anand et al., 2008) . Alcohol consumption has been highly associated to specific cancers such as oral, pharyngeal, laryngeal, esophageal, hepatic, colorectal and breast cancer (IARC, 2012; Roswall and Weiderpass, 2015; Smyth et al., 2015) . In addition, 2.5 alcoholic drinks per day in women and 5 in men represent a higher risk of death due to cancer with respect to people who consume <1 drink per week (Bergmann et al., 2013) . In people diagnosed with some cancers (e.g. breast, oral-pharyngeal-laryngeal, esophageal, stomach, liver or colon cancer) alcohol consumption increases the risk of recurrence and of developing new primary cancers (Palli et al., 2000; Do et al., 2003; Doyle et al., 2006; Nielsen, Nordestgaard, & Bojesen, 2012; Thrift et al., 2012; Araújo et al., 2013; Kwan et al., 2013) . Moreover, if the individuals continue drinking after being diagnosed of cancer their risk of dying is higher compared to those who quit (Palli et al., 2000; Araújo et al., 2013; Huang et al., 2014) . However, some studies suggest that the prevalence of hazardous drinking in people with cancer is the same as in those without cancer (Bellizzi et al., 2005; Coups and Ostroff, 2005) , which may indicate the necessity of programs and interventions to change health behaviors before and after cancer diagnosis.
Guidelines for clinical practice in oncology show no clear consensus regarding alcohol consumption in people diagnosed with cancer. For example, the NCCN Clinical Practice Guidelines in OncologySurvivorship recommend to limit alcohol intake to one drink per day for women and two drinks per day for men (National Comprehensive Cancer Network, 2015) , whereas the American Institute for Cancer Research/World Cancer Research Fund (AICR/WCRF) recommends not to drink any alcoholic drinks (American Institute for Cancer Research, 2007; Barrera and Demark-Wahnefried, 2009 ). These variations in the recommendations, together with the fact that alcohol use is not addressed in comprehensive cancer control plans or programs, may lead to an increased prevalence of drinkers who exceed the maximum recommended alcohol intake (Henley et al., 2014) .
The objective of this study is to estimate the prevalence of hazardous drinking in individuals aged 50 and older who had or had had cancer in 17 European countries and Israel and to analyze the factors associated with their consumption.
METHODS
We used a cross-sectional design, based on the latest data from the SHARE (Survey of Health, Ageing and Retirement in Europe) project for 17 European countries (Austria, Belgium, Czech Republic, Denmark, Estonia, France, Germany, Hungary, Italy, Luxembourg, Netherlands, Poland, Portugal, Spain, Slovenia, Sweden and Switzerland) and Israel (www.share-project.org). Data from Hungary, Poland and Portugal were collected in 2011-2012, while information from the other countries was collected in 2013. The study population consisted of people aged 50 years or older. Sampling was performed independently in each country; all obtained a probabilistic sample, although the exact sample design differed slightly between countries. Weights were established for each country to ensure that the resulting samples were representative of their population and were comparable with those of other countries. The final sample size was 69,509.
The dependent variable, hazardous drinking, was calculated through the adaptation of questions from the SHARE survey to their equivalent in the validated (Gual et al., 2002) Alcohol Use Disorders Identification Test, Consumption (AUDIT-C), as used in other studies (Bosque-Prous et al., 2016; Espelt et al., 2017) . This variable was constructed based on three questions: two assessing hazardous drinking in terms of frequency and quantity of alcohol consumption (During the last 3 months, how often did you drink any alcoholic beverage? On the days that you drink, about how many drinks do you have?), and one assessing binge drinking (How often did you have six or more drinks on one occasion?). Each question had five possible answers, which were ranked from 0 (less alcohol use) to 4 points (more alcohol use), and a final score was calculated by adding the scores from each question. Men and women who scored ≥5 and ≥4 points, respectively, were classified as hazardous drinkers (Gual et al., 2002) .
The main independent variable was 'had or had had cancer' (dichotomous variable: yes/no), built based on the question: Has your physician ever told you that you had cancer?/Do you currently have cancer? Then, the types of cancer were categorized, according to the evidence available (Roswall and Weiderpass, 2015) in: (a) cancers related to alcohol consumption (oral cavity, pharyngeal, laryngeal, esophageal, stomach, colorectal, hepatic, pancreatic and breast cancer) and (b) cancers not related to alcohol consumption (brain, thyroid, lung, ovarian, endometrial, cervical, prostate, testicular, renal, bladder, skin cancer, non-Hodgkin lymphoma and leukemia). Time since cancer diagnosis was also taken into account (≤5 years, >5 years, unknown).
In the analyses we accounted for several variables at individual level, as follows: (a) sociodemographic variables: sex; age; country of residence; marital status (married, divorced/widowed, single); and educational level (no education, primary, secondary, tertiary education); (b) major cancer contributing factors: smoking status (never smoker, former smoker, current smoker); and body mass index (underweight, normal weight, overweight, obese) and (c) health status variables: self-perceived health (excellent/very good/good, regular/bad), as a proxy of cancer prognosis, due to its strong relationship with mortality; and other diseases or chronic conditions (absence of illness, presence of illnesses associated with alcohol consumption or presence of illnesses not associated with alcohol consumption) (Shield et al., 2013) .
ANALYSIS
All the analyses were stratified by sex. First, we described the distribution of all the variables according to the history of cancer. Second, we estimated the prevalence of alcohol-related and non-alcohol related cancers by country. Third, we selected only the individuals that had or had had cancer and: (a) we calculated the distribution of alcohol consumption (abstainers, low-risk drinkers and hazardous drinkers) according to their type of cancer (cancer related or unrelated to alcohol consumption) and the time since cancer diagnosis; (b) In order to determine whether the type of cancer or the time since diagnosis were associated with hazardous drinking independently of other variables we estimated various Poisson regression models with robust variance, obtaining prevalence ratios (PR) with their 95% confidence interval (95% CI), as has been suggested for cross-sectional studies (Espelt et al., 2017) . In the first model, the associations between hazardous drinking and all the independent variables were estimated separately. In the second model, we adjusted for all the independent variables. The analyses were conducted using STATA 14.0. Table 1 shows the distribution of the sample's characteristics by history of cancer diagnosis. The prevalence of cancer in lifetime was 5.6% in women and 5.1% in men aged 50 or older. Of the participants diagnosed with cancer, 47% had an alcohol-related type of cancer, with significant differences between men and women (28 and 61%, respectively). Regarding time since diagnosis, 32% of cancers were diagnosed more than 5 years ago, 25% ≤5 years ago and 43% had an unknown date of diagnosis.
RESULTS
In Table 2 , we show the prevalence of alcohol-related and nonalcohol related cancers by country. The prevalence of alcoholrelated cancers varied in women from 1.0% in Poland to 6.2% in Germany, whereas in men it varied from 0.8% in Israel and Switzerland to 3.0% in Luxembourg. The prevalence of non-alcohol related cancers varied in women from 1.1% in Poland to 4.5% in Luxembourg, while it varied from 2.1% in Portugal to 6.8% in Luxembourg in men.
The differences in the prevalence of hazardous drinking in people with alcohol-related cancers were not statistically significant between men and women [21.3% (95% CI: 16.3-27.4) in men and 18.3% (95% CI: 15.7-21.3) in women]. Nevertheless, these differences were statistically significant in people with non-alcohol related cancers [23.4% (95% CI: 20.3-26.8) in men, and 16.8% (95% CI: 13.9-20.0) in women]. There were no statistically significant differences between hazardous drinking and time since cancer diagnosis (Table 3) .
When taking into account only the individuals who had ever been diagnosed with cancer, we found that the risk of being a hazardous drinker in men was higher than in women [PR = 1.25 (95% CI: 1.05-1.49)], after adjusting for the other individual variables and regardless of the country of residence. Besides, being a hazardous drinker was also associated with: smoking status [PR = 1.23 (95% CI: 0.98-1.53) in former smokers and PR = 1.61 (95% CI: 1.24-2.09) in current smokers compared to never smokers] and selfperceived health [PR = 0.65 (95% CI: 0.54-0.77) in participants with regular or poor self-perceived health compared to those with excellent, very good or good self-perceived health]. No statistically significant differences were found between hazardous drinking and (i) type of cancer; and (ii) time since cancer diagnosis (Table 4) .
DISCUSSION
The prevalence of hazardous drinking in people with cancer was 18% in women and 23% in men. Moreover, taking into account only those participants diagnosed with cancer at least once in their lifetime, there were no significant differences in the prevalence of hazardous drinking depending on the type of cancer (alcohol-related cancers compared to non-alcohol related cancers) and the time since cancer diagnosis. Finally, the highest prevalence of hazardous drinking in people diagnosed with cancer is found in smokers and people with good self-perceived health.
Before discussing these findings further, we would like to point out the main strengths and limitations of this study. As far as we know, this is the first study in Europe that analyzes the prevalence of hazardous drinking in people with cancer and accounts for type of cancer (alcohol-related or non-alcohol related cancers) and time since cancer diagnosis. Besides, this study included a representative sample of non-institutionalized people aged 50 years and older, resident in various European countries. On the other hand, the study could suffer certain limitations. First of all, the prevalence of hazardous drinking was estimated based on self-reported data, which could lead to classification and memory bias due to the fact that the individuals tend to underestimate their own alcohol consumption. Nevertheless, these data were obtained through an adaptation of the AUDIT-C test, which has been validated to detect hazardous drinkers (Frank et al., 2008) . Secondly, one of AUDIT-C test questions is about the number of drinks per occasion, but it does not take the actual alcohol percentage into account. However, when conducting the interview, the interviewer explained to each respondent what amount of alcohol is considered as one alcoholic drink (1 bottle/can of beer = 33 cl, 1 glass table wine = 12 cl, 1 glass fortified wine = 8 cl and 1 glass spirits = 4 cl). Thirdly, our study does not provide information on the severity or the phase of the cancer, which may have allowed us to evaluate the issue of alcohol consumption in people diagnosed with cancer more precisely. However, we accounted for self-perceived health in the analyses, which is not influenced by cultural differences between countries (Carlson, 1998) , and is strongly associated with mortality (DeSalvo et al., 2006) . Fourthly, we could not adjust for the diet of participants in the analysis, which is the environmental factor attributable to the major proportion of cancers (30-35%) (Anand et al., 2008) , due to lack of data. However, we were able to adjust by the body mass index and smoking status, which were the other environmental major contributing factors for cancer.
In our study, the prevalence of hazardous drinking in people with cancer from various European countries was 18% in women and 23% in men. Although hazardous drinking in our study was estimated using another method, this prevalence was similar to the one found in people diagnosed with cancer aged 40 years and older in the United States (Bellizzi et al., 2005) . This non-negligible prevalence should alert clinicians because hazardous drinking leads to various adverse health effects. In fact, these health consequences could be more severe after a diagnosis of cancer, since hazardous drinking worsens cancer prognosis (Palli et al., 2000; Do et al., 2003; Kwan et al., 2010; Araújo et al., 2013; Huang et al., 2014) . In this sense, hazardous drinking could cause adverse reactions to multiple medications and interfere the clinicians' efforts to successfully treat cancer (Weathermon and Crabb, 1999) , could increase the risk of recurrence of certain cancers (Do et al., 2003; Araújo et al., 2013; Kwan et al., 2013) , the likelihood of the onset of new primary cancers (Doyle et al., 2006) and the risk of death (Deleyiannis et al., 1996; Araújo et al., 2013; Kwan et al., 2013; Huang et al., 2014) . Gender differences were also similar to the general population, as men tend to consume more alcohol (in quantity and frequency) than women. Nevertheless, due to changes in social roles in women these differences are decreasing (Bosque-Prous et al., 2015) . This convergence in men and women's drinking behavior has to be taken into account, as hazardous drinking has been related to mortality in women diagnosed with breast cancer (Kwan et al., 2013) . The percentages of the categories in some variables (marital status, migrant background, education level, body mass index and time since cancer diagnosis) do not add up to 100% due to unknown data. a Alcohol-related chronic conditions: heart attack, high-blood pressure, stroke, high-blood cholesterol and diabetes. Non-alcohol related chronic conditions: chronic lung disease, cataracts, hip or femoral fracture, other fractures, Alzheimer's disease, dementia, senility, arthritis, stomach or duodenal ulcer, Parkinson disease.
b Alcohol-related cancers: oral cavity, pharyngeal, laryngeal, esophageal, stomach, liver, colorectal, pancreas, and breast. Non-alcohol related cancers: brain, thyroid, lung, ovary, endometrium, cervix, prostate, testicular, kidney, bladder, skin, non-Hodgkin lymphoma and leukemia.
The prevalence of hazardous drinking found in our study does not statistically differ between hazardous drinking and (a) alcoholrelated and non-related types of cancer and (b) according to the time since cancer diagnosis. These results were consistent with other cross-sectional and longitudinal studies (Bellizzi et al., 2005; Hawkes et al., 2008) , which found no significant differences between hazardous drinking and the time since cancer diagnosis. Williams et al. (2013) in a longitudinal study analyzing the prevalence of hazardous drinking in three periods of time (0-2 years before a cancer diagnosis, 0-2 years post-diagnosis and 2-4 years post-diagnosis) found a slight decrease in alcohol intake by the first assessment after cancer diagnosis, but this was followed by a slight rebound by the next follow-up. This is important as long as the cancer prognosis is related to hazardous drinking.
Cancer survivors who made positive health behavior changes were more likely to do so within 6 months after the diagnosis (Humpel et al., 2007) . However, none of the previous studies, neither longitudinal (Hawkes et al., 2008; Karlsen et al., 2012; Williams et al., 2013) nor cross-sectional (Bellizzi et al., 2005; Coups and Ostroff, 2005) , have found evidence that cancer diagnosis is associated with significant and sustained over time changes in alcohol intake, which could be due to the fact that oncology guidelines do not include specific recommendations on alcohol consumption for the patients. Given that and taking into account the prevalence of hazardous drinking among people diagnosed with cancer found in our study, the inclusion of specific recommendations and interventions in clinical oncology guidelines at the moment of cancer diagnosis would be highly advisable, since the oncologist Table 2 . Prevalence of cancer in lifetime by type of cancer, time since diagnosis and sex in people over 50 from 18 European countries (SHARE project, 2011 (SHARE project, -2013 may play an important role in guiding patients with cancer towards behaviors that improve their overall health (Demark-Wahnefried et al., 2005) . Besides, strategies that emphasize individual counseling and education may have more impact when combined with strategies that emphasize public policies and changes in the context in which health decisions are made (Frieden et al., 2008) .
Time since cancer diagnosis could be an important factor to be taken into account because it could be related to the cancer stage and this latter could be related to alcohol consumption. For example, individuals whose prognosis improved could return to their previous drinking due to the believing that alcohol consumption is not harmful anymore. Conversely, those patients whose prognosis has worsened could have stopped drinking. However, as far as we know, this relationship has not been studied yet. In our study no statistically significant differences in the prevalence of hazardous drinking were found depending on time since cancer diagnosis. Thus, further longitudinal studies collecting data on treatment, cancer stage and time since cancer diagnosis are needed to address this issue in depth (Williams et al., 2013) .
This study also showed that prevalence of hazardous drinking was higher in people with cancer who were current smokers or former smokers and in people with cancer who self-reported good, Alcohol-related chronic conditions: heart attack, high blood pressure, stroke, high blood cholesterol and diabetes. Non-alcohol related chronic conditions: chronic lung disease, cataracts, hip or femoral fracture, other fractures, Alzheimer's disease, dementia, senility, arthritis, stomach or duodenal ulcer, Parkinson disease.
c Alcohol-related cancers: oral cavity, pharyngeal, laryngeal, esophageal, stomach, liver, colorectal, pancreas and breast. Non-alcohol related cancers: brain, thyroid, lung, ovary, endometrium, cervix, prostate, testicular, kidney, bladder, skin, non-Hodgkin lymphoma and leukemia.
very good or excellent health. This fact has relevant public health implications, as alcohol and tobacco consumption combined have an additive and synergic effect in the development and recurrence of cancer (Duffy et al., 2002; Thrift et al., 2012) and also decrease the survival rate in people with specific types of cancer (Fortin et al., 2009) . This fact suggests the need to avoid hazardous drinking and promote changes in health behaviors (Pinto and Trunzo, 2005) . Obesity, physical inactivity, poor dietary quality, smoking and alcohol consumption after being diagnosed with cancer increase the risk of recurrence and mortality. It must be taken into account that health professionals' recommendations are the first fundamental step in patients' motivation to consider a change in lifestyle factors (Demark-Wahnefried et al., 2005) .
CONCLUSION
In Europe, the prevalence of hazardous drinking in people who have had cancer at least once in their lifetime is not negligible, especially given that previous studies showed that alcohol consumption worsens the prognosis of the disease and the probability of cancer recurrence. No significant differences in prevalence of hazardous drinking were found in relation to the type of cancer (related or not to alcohol consumption) or time since cancer diagnosis. These findings reinforce the need of further health professionals' recommendations at the time of diagnosis aimed at inducing changes in alcohol use behaviors and other unhealthy lifestyle factors, such as tobacco smoking, that have been reported to be associated with a reduction of the survival rate and an increased likelihood of cancer recurrence.
